Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial.

PubWeight™: 1.59‹?› | Rank: Top 4%

🔗 View Article (PMID 19633827)

Published in Diabetologia on July 25, 2009

Authors

J W J Beulens1, A Patel, J R Vingerling, J K Cruickshank, A D Hughes, A Stanton, J Lu, S A McG Thom, D E Grobbee, R P Stolk, AdRem project team, ADVANCE management committee

Author Affiliations

1: Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, GA, the Netherlands. J.Beulens@umcutrecht.nl

Associated clinical trials:

Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in High Risk Patients With Type 2 Diabetes | NCT00145925

Articles citing this

Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med (2010) 10.75

Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. BMJ (2011) 2.49

Blood pressure control for diabetic retinopathy. Cochrane Database Syst Rev (2015) 2.19

The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study. Ophthalmology (2014) 1.89

Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy. Mediators Inflamm (2012) 1.02

Does tight control of systemic factors help in the management ofdiabetic retinopathy? Indian J Ophthalmol (2016) 0.99

Prediction, by retinal location, of the onset of diabetic edema in patients with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci (2011) 0.87

Body mass index: a risk factor for retinopathy in type 2 diabetic patients. Mediators Inflamm (2013) 0.85

Diabetic microvascular complications: possible targets for improved macrovascular outcomes. Int J Nephrol Renovasc Dis (2010) 0.83

Blood pressure, vessel caliber, and retinal thickness in diabetes. Optom Vis Sci (2012) 0.81

Systemic medical management of diabetic retinopathy. Middle East Afr J Ophthalmol (2013) 0.80

Diabetic Retinopathy-Update on Prevention Techniques, Present Therapies, and New Leads. US Ophthalmic Rev (2014) 0.80

One size does not fit all glycemic targets for type 2 diabetes. J Diabetes Investig (2014) 0.80

2013 Korean Society of Hypertension guidelines for the management of hypertension: part III-hypertension in special situations. Clin Hypertens (2015) 0.79

The Effect of Bariatric Surgery on Diabetic Retinopathy: Good, Bad, or Both? Diabetes Metab J (2016) 0.79

A five-year prospective study of diabetic retinopathy progression in chinese type 2 diabetes patients with "well-controlled" blood glucose. PLoS One (2015) 0.78

Optimal treatment of diabetic retinopathy. Ther Adv Endocrinol Metab (2013) 0.78

[Diabetic maculopathy and retinopathy. Functional and sociomedical significance]. Ophthalmologe (2010) 0.77

Effects of intensive control of blood glucose and blood pressure on microvascular complications in patients with type II diabetes mellitus. Int J Ophthalmol (2013) 0.77

Prevalence and risk factors of diabetes and diabetic retinopathy in Liaoning province, China: a population-based cross-sectional study. PLoS One (2015) 0.76

Complementary mechanisms of action and rationale for the fixed combination of perindopril and indapamide in treating hypertension - update on clinical utility. Integr Blood Press Control (2010) 0.76

Overview of Ocular Anti-Vascular Endothelial Growth Factor Therapy in the Management of Diabetic Eye Complications. Diabetes Spectr (2016) 0.75

Body mass index and risk of diabetic retinopathy: A meta-analysis and systematic review. Medicine (Baltimore) (2017) 0.75

Prevention of complications in type 2 diabetes: is drug glucose control evidence based? Br J Gen Pract (2017) 0.75

Pregnancy glycemia to vascular risk: nonglycemic diabetes? CMAJ (2009) 0.75

Type 2 diabetes: cost-effectiveness of medication adherence and lifestyle interventions. Patient Prefer Adherence (2016) 0.75

Body mass index and retinopathy in type 1 diabetic patients. Int J Endocrinol (2014) 0.75

Soluble plasma proteins ST2 and CD163 as early biomarkers of nephropathy in Swedish patients with diabetes, 15-34 years of age: a prospective cohort study. Diabetol Metab Syndr (2017) 0.75

Articles by these authors

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet (2007) 14.96

Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature (2000) 8.59

Genome of the bacterium Streptococcus pneumoniae strain R6. J Bacteriol (2001) 7.97

Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol (1991) 7.67

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med (1999) 7.56

Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology (1999) 7.55

Difficult Airway Society Guidelines for the management of tracheal extubation. Anaesthesia (2012) 7.19

Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation (1997) 7.03

Assessment of the sensitivity and specificity of oligonucleotide (50mer) microarrays. Nucleic Acids Res (2000) 6.20

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA (1998) 5.87

Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ (1991) 5.45

Diuretics, beta-blockers, and the risk for sudden cardiac death in hypertensive patients. Ann Intern Med (1995) 5.12

The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology (1995) 5.08

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet (1997) 5.04

Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol (1998) 4.91

Cardiovascular mortality in Dutch men during 1996 European football championship: longitudinal population study. BMJ (2001) 4.87

Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys (1999) 4.72

Simulation of Sahel drought in the 20th and 21st centuries. Proc Natl Acad Sci U S A (2005) 4.70

Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science (2000) 4.57

The epidemiology of heart failure. Eur Heart J (1997) 4.31

Heart attack, stroke, diabetes, and hypertension in West Indians, Asians, and whites in Birmingham, England. Br Med J (1980) 4.28

PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc Natl Acad Sci U S A (1993) 4.05

The frequency of uterine leiomyomas. Am J Clin Pathol (1990) 4.00

Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke (2001) 3.99

Early outcome after off-pump versus on-pump coronary bypass surgery: results from a randomized study. Circulation (2001) 3.96

J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet (1994) 3.95

Comparative sequence analysis of a gene-rich cluster at human chromosome 12p13 and its syntenic region in mouse chromosome 6. Genome Res (1998) 3.80

Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology (1994) 3.75

Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care (2000) 3.75

Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens (2012) 3.73

Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res (1996) 3.60

ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol (2001) 3.55

The sedative component of anesthesia is mediated by GABA(A) receptors in an endogenous sleep pathway. Nat Neurosci (2002) 3.52

External validation is necessary in prediction research: a clinical example. J Clin Epidemiol (2003) 3.49

Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ (1995) 3.42

Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol (1998) 3.37

The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology (1994) 3.30

Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey. Clin Pharmacol Ther (2012) 3.22

Changing views on open-angle glaucoma: definitions and prevalences--The Rotterdam Study. Invest Ophthalmol Vis Sci (2000) 3.19

Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J (1999) 3.18

Randomized clinical trial of early laparoscopy in the management of acute non-specific abdominal pain. Br J Surg (1999) 3.18

Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet (1989) 3.12

Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res (1988) 3.10

The prognosis of heart failure in the general population: The Rotterdam Study. Eur Heart J (2001) 3.07

PATRIC: the VBI PathoSystems Resource Integration Center. Nucleic Acids Res (2006) 3.06

Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. Circulation (2005) 2.99

Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia (1997) 2.82

Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet (1998) 2.82

Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol (1996) 2.80

Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke (1997) 2.79

Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med (2000) 2.79

Melanopsin in cells of origin of the retinohypothalamic tract. Nat Neurosci (2001) 2.79

SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells. Antimicrob Agents Chemother (2006) 2.75

Human homologues of yeast helicase. Nature (1996) 2.71

Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam Study. Ann Intern Med (1995) 2.70

In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol (1990) 2.70

Rapid viral diagnosis of acute respiratory infections: comparison of enzyme-linked immunosorbent assay and the immunofluorescence technique for detection of viral antigens in nasopharyngeal secretions. J Clin Microbiol (1985) 2.69

Lyme arthritis in the Hunter Valley. Med J Aust (1982) 2.68

Microscopic satellitosis in patients with primary cutaneous melanoma: implications for nodal basin staging. Ann Surg Oncol (2009) 2.67

Student views on continuous assessment at Birmingham University Medical School. Br Med J (1975) 2.63

Requirement of the MADS-box transcription factor MEF2C for vascular development. Development (1998) 2.63

The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol Cell Biol (1991) 2.63

Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ (1994) 2.60

The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev (1998) 2.58

Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol (2003) 2.57

Nitriding iron at lower temperatures. Science (2003) 2.55

Contraction-induced changes in acetyl-CoA carboxylase and 5'-AMP-activated kinase in skeletal muscle. J Biol Chem (1997) 2.54

Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med (1999) 2.53

The preregistration year: Chaos by consensus. Lancet (1977) 2.50

Is carotid intima-media thickness useful in cardiovascular disease risk assessment? The Rotterdam Study. Stroke (2001) 2.49

A high-density integrated genetic linkage and radiation hybrid map of the laboratory rat. Genome Res (1999) 2.49

Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J (2002) 2.49

A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab (1998) 2.45

Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study. Am J Epidemiol (1996) 2.45

Tobacco cessation interventions for young people. Cochrane Database Syst Rev (2006) 2.43

Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ (2001) 2.43

Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study. Ophthalmology (1995) 2.43

Does drug treatment improve survival? Reconciling the trials in mild-to-moderate hypertension. J Hypertens (1995) 2.40

Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab (2000) 2.36

Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med (2001) 2.35

Diverse forms of a receptor for acidic and basic fibroblast growth factors. Mol Cell Biol (1990) 2.33

Comparison between measures of atherosclerosis and risk of stroke: the Rotterdam Study. Stroke (2003) 2.31

Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology (1995) 2.30

Limitations of sensitivity, specificity, likelihood ratio, and bayes' theorem in assessing diagnostic probabilities: a clinical example. Epidemiology (1997) 2.28

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia (2011) 2.28

Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources. Proc Natl Acad Sci U S A (1985) 2.26

Cardiovascular risk prediction tools for populations in Asia. J Epidemiol Community Health (2007) 2.25

Carotid intima-media thickness at different sites: relation to incident myocardial infarction; The Rotterdam Study. Eur Heart J (2002) 2.22

Fewer sore throats and a better seal: why routine manometry for laryngeal mask airways must become the standard of care. Anaesthesia (2014) 2.21

A randomised controlled trial of cognitive behaviour therapy and motivational interviewing for people with Type 1 diabetes mellitus with persistent sub-optimal glycaemic control: a Diabetes and Psychological Therapies (ADaPT) study. Health Technol Assess (2010) 2.20

Deafness and imbalance associated with inactivation of the secretory Na-K-2Cl co-transporter. Nat Genet (1999) 2.20

Better blood pressure control: how to combine drugs. J Hum Hypertens (2003) 2.19

Nitric oxide synthase gene polymorphisms and diabetic nephropathy. Diabetologia (2003) 2.18

Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study. J Neurol Neurosurg Psychiatry (2003) 2.18

Recombinant rat CBF-C, the third subunit of CBF/NFY, allows formation of a protein-DNA complex with CBF-A and CBF-B and with yeast HAP2 and HAP3. Proc Natl Acad Sci U S A (1995) 2.17

Smoking, quitting, and the risk of cardiovascular disease among women and men in the Asia-Pacific region. Int J Epidemiol (2005) 2.16